Nureca Share Price
Sector: Medical Equipment & Supplies
228.80 -4.65 (-1.99%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
228.80
Today’s High
228.80
52 Week Low
198.00
52 Week High
447.00
226.38 -4.63 (-2.00%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
226.38
Today’s High
230.01
52 Week Low
203.62
52 Week High
447.50
Key Metrics
- Market Cap (In Cr) 228.8
- Beta 1.03
- Div. Yield (%) 0
- P/B 1.17
- TTM P/E -
- Sector P/E 23.91
- Open Price 228.8
- Prev Close 233.45
Nureca Analysis
Price Analysis
-
1 Week-7.88%
-
3 Months-21.72%
-
6 Month-24.05%
-
YTD-19.99%
-
1 Year-21.64%
Risk Meter
- 59% Low risk
- 59% Moderate risk
- 59% Balanced Risk
- 59% High risk
- 59% Extreme risk
Nureca News
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy
1 min read . 05 Sep 2024Bulk deals: Abans Holdings Ltd, HEG, others exchange hands, Check list here
1 min read . 02 Jun 2023Nureca share price hits 52-week low on bulk deal by promoter Payal Goyal
1 min read . 29 Nov 2022Nureca Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 91.93
- Selling/ General/ Admin Expenses Total
- 41.52
- Depreciation/ Amortization
- 2.36
- Other Operating Expenses Total
- 0
- Total Operating Expense
- 104.49
- Operating Income
- -12.57
- Net Income Before Taxes
- -2.54
- Net Income
- -1.79
- Diluted Normalized EPS
- -1.79
- Period
- 2024
- Total Assets
- 205.17
- Total Liabilities
- 12.05
- Total Equity
- 193.11
- Tangible Book Valueper Share Common Eq
- 190.81
- Period
- 2024
- Cashfrom Operating Activities
- -2.71
- Cashfrom Investing Activities
- 17.58
- Cashfrom Financing Activities
- -1.3
- Net Changein Cash
- 13.56
- Period
- 2023
- Total Revenue
- 111.32
- Selling/ General/ Admin Expenses Total
- 50.61
- Depreciation/ Amortization
- 2.39
- Total Operating Expense
- 128.72
- Operating Income
- -17.4
- Net Income Before Taxes
- -10.74
- Net Income
- -8.25
- Diluted Normalized EPS
- -8.25
- Period
- 2023
- Total Assets
- 206.58
- Total Liabilities
- 11.7
- Total Equity
- 194.88
- Tangible Book Valueper Share Common Eq
- 192.27
- Period
- 2023
- Cashfrom Operating Activities
- 10.23
- Cashfrom Investing Activities
- -16.46
- Cashfrom Financing Activities
- -1.51
- Net Changein Cash
- -7.75
- Period
- 2022
- Total Revenue
- 255.55
- Selling/ General/ Admin Expenses Total
- 67.26
- Depreciation/ Amortization
- 1.48
- Total Operating Expense
- 201.52
- Operating Income
- 54.03
- Net Income Before Taxes
- 60.98
- Net Income
- 44.96
- Diluted Normalized EPS
- 44.96
- Period
- 2022
- Total Assets
- 219.13
- Total Liabilities
- 15.93
- Total Equity
- 203.2
- Tangible Book Valueper Share Common Eq
- 200.38
- Period
- 2022
- Cashfrom Operating Activities
- 1.4
- Cashfrom Investing Activities
- -3.09
- Cashfrom Financing Activities
- -7.3
- Net Changein Cash
- -8.99
- Period
- 2021
- Total Revenue
- 213.45
- Selling/ General/ Admin Expenses Total
- 52.1
- Depreciation/ Amortization
- 0.42
- Other Operating Expenses Total
- 0.32
- Total Operating Expense
- 152.33
- Operating Income
- 61.12
- Net Income Before Taxes
- 62.33
- Net Income
- 46.37
- Diluted Normalized EPS
- 46.37
- Period
- 2021
- Total Assets
- 185.75
- Total Liabilities
- 22.65
- Total Equity
- 163.1
- Tangible Book Valueper Share Common Eq
- 162.79
- Period
- 2021
- Cashfrom Operating Activities
- 34.87
- Cashfrom Investing Activities
- -110.04
- Cashfrom Financing Activities
- 92.34
- Net Changein Cash
- 17.17
- Period
- 2020
- Total Revenue
- 99.43
- Selling/ General/ Admin Expenses Total
- 24.53
- Depreciation/ Amortization
- 0.37
- Other Operating Expenses Total
- 0.56
- Total Operating Expense
- 90.11
- Operating Income
- 9.32
- Net Income Before Taxes
- 8.61
- Net Income
- 6.4
- Diluted Normalized EPS
- 6.39
- Period
- 2020
- Total Assets
- 33.88
- Total Liabilities
- 18.95
- Total Equity
- 14.93
- Tangible Book Valueper Share Common Eq
- 14.93
- Period
- 2020
- Cashfrom Operating Activities
- -7.92
- Cashfrom Investing Activities
- -0.39
- Cashfrom Financing Activities
- 8.28
- Net Changein Cash
- -0.04
- Period
- 2024-12-31
- Total Revenue
- 26.46
- Selling/ General/ Admin Expenses Total
- 3.84
- Depreciation/ Amortization
- 0.54
- Other Operating Expenses Total
- 10.1
- Total Operating Expense
- 31.02
- Operating Income
- -4.55
- Net Income Before Taxes
- -3.25
- Net Income
- -2.8
- Diluted Normalized EPS
- -2.8
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 31.19
- Selling/ General/ Admin Expenses Total
- 3.63
- Depreciation/ Amortization
- 0.62
- Other Operating Expenses Total
- 9.64
- Total Operating Expense
- 34.17
- Operating Income
- -2.98
- Net Income Before Taxes
- -0.08
- Net Income
- -0.48
- Diluted Normalized EPS
- -0.48
- Period
- 2024-09-30
- Total Assets
- 214.96
- Total Liabilities
- 20.65
- Total Equity
- 194.31
- Tangible Book Valueper Share Common Eq
- 192.17
- Period
- 2024-09-30
- Cashfrom Operating Activities
- -5.44
- Cashfrom Investing Activities
- -7.12
- Cashfrom Financing Activities
- 0.73
- Net Changein Cash
- -11.83
- Period
- 2024-06-30
- Total Revenue
- 20.27
- Selling/ General/ Admin Expenses Total
- 3.57
- Depreciation/ Amortization
- 0.66
- Other Operating Expenses Total
- 6.84
- Total Operating Expense
- 23.29
- Operating Income
- -3.03
- Net Income Before Taxes
- 2.62
- Net Income
- 1.66
- Diluted Normalized EPS
- 1.66
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 16.97
- Selling/ General/ Admin Expenses Total
- 3.07
- Depreciation/ Amortization
- 0.6
- Other Operating Expenses Total
- 7.15
- Total Operating Expense
- 22
- Operating Income
- -5.03
- Net Income Before Taxes
- -6.47
- Net Income
- -4.15
- Diluted Normalized EPS
- -4.16
- Period
- 2024-03-31
- Total Assets
- 205.17
- Total Liabilities
- 12.05
- Total Equity
- 193.11
- Tangible Book Valueper Share Common Eq
- 190.81
- Period
- 2024-03-31
- Cashfrom Operating Activities
- -2.71
- Cashfrom Investing Activities
- 17.58
- Cashfrom Financing Activities
- -1.3
- Net Changein Cash
- 13.56
- Period
- 2023-12-31
- Total Revenue
- 22.37
- Selling/ General/ Admin Expenses Total
- 3.28
- Depreciation/ Amortization
- 0.59
- Other Operating Expenses Total
- 7.47
- Total Operating Expense
- 27.22
- Operating Income
- -4.85
- Net Income Before Taxes
- 0.95
- Net Income
- 0.16
- Diluted Normalized EPS
- 0.16
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 31.35
- Selling/ General/ Admin Expenses Total
- 3.07
- Depreciation/ Amortization
- 0.59
- Other Operating Expenses Total
- 7.77
- Total Operating Expense
- 30.56
- Operating Income
- 0.8
- Net Income Before Taxes
- 3.91
- Net Income
- 2.89
- Diluted Normalized EPS
- 2.9
- Period
- 2023-09-30
- Total Assets
- 208.99
- Total Liabilities
- 11.95
- Total Equity
- 197.04
- Tangible Book Valueper Share Common Eq
- 194.58
- Period
- 2023-09-30
- Cashfrom Operating Activities
- -14.53
- Cashfrom Investing Activities
- 16.37
- Cashfrom Financing Activities
- -0.76
- Net Changein Cash
- 1.07
- Period
- 2023-06-30
- Total Revenue
- 21.23
- Selling/ General/ Admin Expenses Total
- 2.79
- Depreciation/ Amortization
- 0.58
- Other Operating Expenses Total
- 6.92
- Total Operating Expense
- 24.72
- Operating Income
- -3.49
- Net Income Before Taxes
- -0.93
- Net Income
- -0.71
- Diluted Normalized EPS
- -0.71
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 21.23
- Selling/ General/ Admin Expenses Total
- 2.79
- Depreciation/ Amortization
- 0.56
- Other Operating Expenses Total
- 7.57
- Total Operating Expense
- 25.24
- Operating Income
- -4.02
- Net Income Before Taxes
- -1.97
- Net Income
- -1.53
- Diluted Normalized EPS
- -1.53
- Period
- 2023-03-31
- Total Assets
- 206.58
- Total Liabilities
- 11.7
- Total Equity
- 194.88
- Tangible Book Valueper Share Common Eq
- 192.27
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 10.23
- Cashfrom Investing Activities
- -16.46
- Cashfrom Financing Activities
- -1.51
- Net Changein Cash
- -7.75
- Period
- 2022-12-31
- Total Revenue
- 27.79
- Selling/ General/ Admin Expenses Total
- 3.99
- Depreciation/ Amortization
- 0.6
- Other Operating Expenses Total
- 8
- Total Operating Expense
- 29.31
- Operating Income
- -1.52
- Net Income Before Taxes
- 0.27
- Net Income
- 0.3
- Diluted Normalized EPS
- 0.3
- Period
- 2022-12-31
- Period
- 2022-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Nureca Technical
Moving Average
SMA
- 5 Day242.94
- 10 Day242.73
- 20 Day229.1
- 50 Day238.46
- 100 Day275.02
- 300 Day286.23
Nureca Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Mallcom (india)
- 1137
- 33.75
- 3.06
- 1780
- 937.2
- 706.45
- Prevest Denpro
- 468.15
- -2
- -0.43
- 686
- 351
- 559.72
- Nureca
- 228.8
- -4.65
- -1.99
- 447
- 198
- 228.8
- One Global Service Provider
- 295.2
- -6
- -1.99
- 407.6
- 82
- 209.73
- Royal Sense
- 234.35
- 0
- 0
- 316.05
- 111
- 114.83
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Mallcom (india)
- 18.87
- 2.88
- 19.31
- 8.48
- Prevest Denpro
- 34.97
- 6.37
- 25.07
- 29.12
- Nureca
- -
- 1.2
- -
- -
- One Global Service Provider
- 30.09
- 14.86
- 39.6
- 12.73
- Royal Sense
- 72.27
- 6.3
- -
- -
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 05-May-25
- Audited Results
- 24-Jan-25
- Quarterly Results
- 24-Oct-24
- Quarterly Results
- 05-Aug-24
- Quarterly Results
- 15-May-24
- Audited Results
- 07-Feb-24
- Quarterly Results
- 04-Nov-23
- Quarterly Results
- 10-Aug-23
- Quarterly Results
- 23-May-23
- Audited Results & A.G.M.
- 03-Feb-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 01-Apr-25
- 25-Feb-25
- POM
- 20-Jul-23
- 24-May-23
- AGM
- 29-Sept-21
- 02-Aug-21
- AGM
- -
- 15-May-24
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 14-Feb-22
- 25-Feb-22
- 24-Feb-22
- 3
- 16-Jun-21
- -
- 21-Sept-21
- 2


